Nanoswitches for tumor targeting
SPRIND to finance spin-off Plectonic
30-Nov-2022 -
The Federal Agency for Disruptive Innovation SPRIND will provide funding for the work of Plectonic Biotech in the coming years. The TUM spin-off has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of immunotherapies that target tumors ...
antibodies
cancer
cancer immunotherapies
+4